Dr. Clint E. Behrend, MD

Dr. Behrend practices at Mountain View Hospital in Idaho Falls, Idaho, part of Intermountain Health.

Dr. Behrend's NPI, 1538138243, was assigned on March 15, 2006. Dr. Behrend graduated from University of Maryland School of Medicine in 1992. Dr. Behrend holds Idaho license M7328.

Dr. Behrend's primary practice is Mountain View Hospital, at 2325 Coronado Street, Idaho Falls, ID 83404 in Bonneville County. The practice phone is (208) 557-2700.

Dr. Behrend's primary practice is Mountain View Hospital in Idaho Falls, Idaho, part of Intermountain Health. Dr. Behrend is also affiliated with Eastern Idaho Regional Medical Center. The medical group on file is Mountain View Hospital. Dmand AI also links Dr. Behrend to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Behrend's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behrend practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Behrend's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Behrend is licensed in Idaho.

CMS data shows 812 Medicare services from Dr. Behrend across 14 procedure codes in 2024, for 470 Medicare patients. Medicare paid $73,985 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 470 Medicare patients who saw Dr. Behrend in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Behrend's median patient age at 72, with 62% women.

In 2024, Dr. Behrend wrote 2,666 Medicare Part D claims for 610 patients. 88% of them were for generic drugs. CMS names the drug for 2,470 of them, across 31 drugs with 11 or more claims each, at $172,066 in total drug cost. In 2023, CMS named 2,549 claims across 33 drugs.

Dr. Behrend accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 276 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Behrend, more than 94% of the clinicians it reports for that procedure.

Dmand AI links Dr. Behrend to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Colitis, Ulcerative and Colitis. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Behrend that name 4 trials.

CMS Open Payments shows 328 general payments to Dr. Behrend from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $5,944. It also lists 14 research payments totaling $62,180 from 2018 to 2021, naming 4 clinical trials.

Dr. Behrend graduated from University of Maryland School of Medicine in 1992.